Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-01T19:05:46.631Z Has data issue: false hasContentIssue false

Impact of infectious diseases consultation for hospitalized patients with Clostridioides difficile infection

Published online by Cambridge University Press:  15 February 2024

Mara Cranis
Affiliation:
Department of Infection Prevention and Control, Trinity Health, Ann Arbor, MI, USA Department of Infection Prevention and Control, Trinity Health, Livonia, MI, USA
Azza Elamin
Affiliation:
Department of Internal Medicine, Infectious Diseases, Trinity Health, Ann Arbor, MI, USA
Brianna Hatch-Vallier
Affiliation:
Department of Internal Medicine, Infectious Diseases, Trinity Health, Ann Arbor, MI, USA
Curtis D. Collins
Affiliation:
Department of Pharmacy Services, Trinity Health, Ann Arbor, MI, USA
Anurag N. Malani*
Affiliation:
Department of Infection Prevention and Control, Trinity Health, Ann Arbor, MI, USA Department of Internal Medicine, Infectious Diseases, Trinity Health, Ann Arbor, MI, USA
*
Corresponding author: Anurag Malani; Email: Anurag.Malani@trinity-health.org

Abstract

Clostridioides difficile infection (CDI) is associated with substantial morbidity and mortality. This study described outcomes associated with mandatory infectious diseases (ID) consultation in hospitalized patients with CDI. ID consultation was associated with increased appropriate concomitant antibiotic use, however longer courses of concomitant antibiotics were administered.

Type
Concise Communication
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019.Google Scholar
Guh, AY, Mu, Y, Winston, LG, et al. Trends in U.S. burden of Clostridioides difficile infection and outcomes. N Engl J Med 2020;382:13201330.CrossRefGoogle ScholarPubMed
Brumley, PE, Malani, AN, Kabara, JJ, Pisani, J, Collins, CD. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection. J Antimicrob Chemother 2016;71:836840.CrossRefGoogle ScholarPubMed
Bai, AD, Showler, A, Burry, L, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis 2015;60:14511461.CrossRefGoogle ScholarPubMed
Mejia-Chew, C, O’Halloran, JA, Olsen, MA, et al. Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study. Lancet Infect Dis 2019;19:13361344.CrossRefGoogle ScholarPubMed
Shulder, S, Tamma, PD, Fiawoo, S, et al. Infectious diseases consultation associated with reduced mortality in gram-negative bacteremia [published online ahead of print, 2023 Jul 4]. Clin Infect Dis 2023;77:12341237z.CrossRefGoogle ScholarPubMed
Cowen, ME, Czerwinski, JL, Posa, PJ, et al. Implementation of a mortality prediction rule for real-time decision making: feasibility and validity. J Hosp Med 2014;9:720726.CrossRefGoogle ScholarPubMed
National Healthcare Safety Network. Multidrug-Resistant Organism & Clostridiodes difficile Infection (MDRO/CDI) Module, Centers for Disease Control and Prevention 2023. MDRO & CDI Protocol (cdc.gov).Google Scholar
McDonald, LC, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:e1e48.CrossRefGoogle Scholar
Olmedo, M, Valerio, M, Reigadas, E, et al. Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention. JAC Antimicrob Resist 2020;2:dlaa037.CrossRefGoogle ScholarPubMed